Technical Analysis for GRCE - Grace Therapeutics, Inc.
Grade | Last Price | % Change | Price Change |
---|---|---|---|
B | 3.10 | -3.13% | -0.10 |
GRCE closed down 3.13 percent on Friday, November 1, 2024, on approximately normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
Earnings due: Nov 11
*** please verify all earnings dates ***ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Up | Up | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Gapped Down | Weakness | 0.00% | |
Oversold Stochastic | Weakness | 0.00% | |
20 DMA Resistance | Bearish | -3.13% | |
Non-ADX 1,2,3,4 Bullish | Bullish Swing Setup | -3.13% | |
Calm After Storm | Range Contraction | -3.13% | |
Doji - Bullish? | Reversal | -3.13% | |
Stochastic Reached Oversold | Weakness | -3.13% | |
Gapped Up | Strength | -3.13% | |
Oversold Stochastic | Weakness | -3.13% | |
20 DMA Resistance | Bearish | 0.00% |
Alert | Time |
---|---|
Down 5% | about 21 hours ago |
Down 3% | about 24 hours ago |
Fell Below Previous Day's Low | about 24 hours ago |
Down 2 % | about 24 hours ago |
Down 1% | about 24 hours ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 11/11/2024
Grace Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of pharmaceutical applications of its licensed rights for cardiovascular diseases. It focuses on the research of prescription drugs using omega-3, fatty acids derived from krill oil. The company was founded by Henri Harland and Pierre Lemieux on February 1, 2002, and is headquartered in Princeton, NJ.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biopharmaceutical Pharmacy Medication Cardiovascular Disease Pharmaceutical Applications
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biopharmaceutical Pharmacy Medication Cardiovascular Disease Pharmaceutical Applications
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 3.6 |
52 Week Low | 1.98 |
Average Volume | 34,008 |
200-Day Moving Average | 2.93 |
50-Day Moving Average | 2.89 |
20-Day Moving Average | 3.27 |
10-Day Moving Average | 3.29 |
Average True Range | 0.21 |
RSI (14) | 48.19 |
ADX | 26.65 |
+DI | 18.51 |
-DI | 15.10 |
Chandelier Exit (Long, 3 ATRs) | 2.97 |
Chandelier Exit (Short, 3 ATRs) | 3.63 |
Upper Bollinger Bands | 3.54 |
Lower Bollinger Band | 3.00 |
Percent B (%b) | 0.18 |
BandWidth | 16.55 |
MACD Line | 0.08 |
MACD Signal Line | 0.13 |
MACD Histogram | -0.0501 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 3.35 | ||||
Resistance 3 (R3) | 3.35 | 3.26 | 3.31 | ||
Resistance 2 (R2) | 3.26 | 3.20 | 3.26 | 3.30 | |
Resistance 1 (R1) | 3.18 | 3.16 | 3.14 | 3.18 | 3.28 |
Pivot Point | 3.09 | 3.09 | 3.07 | 3.09 | 3.09 |
Support 1 (S1) | 3.01 | 3.03 | 2.97 | 3.02 | 2.92 |
Support 2 (S2) | 2.92 | 2.99 | 2.92 | 2.90 | |
Support 3 (S3) | 2.84 | 2.92 | 2.89 | ||
Support 4 (S4) | 2.85 |